Back to Search
ANDREW ZHU, MD PHD
MD PHD
Medical Oncology Physician
NPI: 1699741769Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
206924(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
206924(MA)
Research & Publications (20)
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.
PMID 19470923·J Clin Oncol·2009
8-other
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy.
PMID 19147690·Oncologist·2009
8-other
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumors.
PMID 19118068·Clin Cancer Res·2009
3-trial
Early development of sunitinib in hepatocellular carcinoma.
PMID 19105714·Expert Rev Anticancer Ther·2009
6-review
Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.
PMID 18305056·Oncologist·2008
3-trial
Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma.
PMID 18041064·Cancer·2008
8-other
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.
PMID 17583545·Cancer·2007
3-trial
Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies.
PMID 17299451·J Cereb Blood Flow Metab·2007
7-preclinical
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
PMID 16786333·Cancer Chemother Pharmacol·2007
3-trial
Case records of the Massachusetts General Hospital. Case 13-2006. A 50-year-old man with a painful bone mass and lesions in the liver.
PMID 16641400·N Engl J Med·2006
5-case
Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.
PMID 16622265·J Clin Oncol·2006
3-trial
Cholangiocarcinoma in association with Thorotrast exposure.
PMID 15619021·J Hepatobiliary Pancreat Surg·2004
5-case
Adjuvant therapy for pancreatic cancer: an evolving paradigm.
PMID 15350937·Surg Oncol Clin N Am·2004
6-review
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer.
PMID 15025795·Clin Colorectal Cancer·2004
8-other
Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer.
PMID 14586834·Semin Radiat Oncol·2003
6-review
[Improved efficacy of P277 fused to heat shock protein 65 of Mycobacterium tuberculosis against diabetes in nonobese diabetic mice].
PMID 18616176·Sheng Wu Gong Cheng Xue Bao·2008
7-preclinical
Pentanuclear and heptanuclear helicates by self-assembly of d10 metal ions and a rigid aromatic bis-bidentate chelator.
PMID 18605688·Inorg Chem·2008
8-other
The negative rejection of H+ in NF of carbonate solution and its influences on membrane performance.
PMID 17250866·Chemosphere·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT ST, BIGELOW TEACHING SERVICE INPATIENT GRB 740
BOSTON, MA 02114 - Phone
- (617) 724-6193
Quick Facts
- NPI
- 1699741769
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile